Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Sponsor: NGM Biopharmaceuticals, Inc
Summary
A multi-center evaluation of NGM120 in a randomized, double-blind, placebo-controlled study in participants with colorectal cancer who have cancer cachexia.
Official title: A Phase 2, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of NGM120 in Participants With Colorectal Cancer Who Have Cancer Cachexia
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
136
Start Date
2025-06-25
Completion Date
2027-12
Last Updated
2026-04-01
Healthy Volunteers
No
Interventions
NGM120 Q4W
NGM120 given subcutaneously every 4 weeks
NGM120 Q8W
NGM120 given subcutaneously every 8 weeks
Placebo given
Placebo given subcutaneously every 4 weeks
Locations (28)
NGM Clinical Study Site
Los Angeles, California, United States
NGM Clinical Study Site
Los Angeles, California, United States
NGM Clinical Study Site
Santa Rosa, California, United States
NGM Clinical Study Site
Margate, Florida, United States
NGM Clinical Study Site
Baltimore, Maryland, United States
NGM Clinical Study Site
New York, New York, United States
NGM Clinical Study Site
Toledo, Ohio, United States
NGM Clinical Study Site
Youngstown, Ohio, United States
NGM Clinical Study Site
Dallas, Texas, United States
NGM Clinical Study Site
Kingwood, Texas, United States
NGM Clinical Study Site
Laredo, Texas, United States
NGM Clinical Study Site
Richmond, Virginia, United States
NGM Clinical Study Site
Appleton, Wisconsin, United States
NGM Clinical Study Site
Tbilisi, Georgia
NGM Clinical Study Site
Tbilisi, Georgia
NGM Clinical Study Site
Tbilisi, Georgia
NGM Clinical Study Site
Tbilisi, Georgia
NGM Clinical Study Site
Tbilisi, Georgia
NGM Clinical Study Site
Goyang, South Korea
NGM Clinical Study Site
Goyang, South Korea
NGM Clinical Study Site
Incheon, South Korea
NGM Clinical Study Site
Seoul, South Korea
NGM Clinical Study Site
Seoul, South Korea
NGM Clinical Study Site
Seoul, South Korea
NGM Clinical Study Site
Suwon, South Korea
NGM Clinical Study Site
Taichung, Taiwan
NGM Clinical Study Site
Taipei, Taiwan
NGM Clinical Study Site
Taoyuan District, Taiwan